Molecular Profile of Advanced Cutaneous Squamous Cell Carcinoma

Jordan Jones1,2,3, Megan Wetzel1,2,3, Timothy Brown1,2,3

  • 1Drs. Jones and Brown are with the Division of Dermatology of the Department of Medicine at the University of Louisville in Louisville, Kentucky.

Summary

Advanced cutaneous squamous cell carcinoma (cSCC) patients may benefit from targeted therapy. Identifying unique genetic mutations, like ERBB3, can guide treatment and improve outcomes in difficult-to-treat cases.